Skip to contentE
Endovia Health Sciences, Inc.
E
EDVAEndovia Health Sciences, Inc. Q2 2026 · 10-Q
Revenue$0.00$0.00derivedno prior Q2 2025 on file Net Income-$2.05M-$2.05MN/M vs Q2 2025 EPS Diluted-$0.77-$0.77N/M vs Q2 2025 The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Endovia Health Sciences, Inc. · CIK 1553788 · Engraved from SEC EDGAR
Operating Income-$2,007,366N/M Operating Cash Flowderived-$1,091,680N/M ended Jun 30, 2026 · filed Aug 19, 2026 · 50 d after period end